Team Life Sciences
Press
Frankfurt-based blockchain start-up Agora Innovation Closes a Seven-digit Pre-series A financing from FinLab EOS VC
FinLab EOS VC makes a seven-digit Euro investment into Agora Innovation GmbH. The Frankfurt-based blockchain start-up will extend its marketing and sales activities and aims to enter European and Asian markets. The access to the EOS blockchain enables the company’s reach for its market leading IVE.ONE software.
Frankfurt’s Agora Innovation announced today a seven-digit pre-series A investment from FinLab EOS VC, a venture capital fund backed by Block.one, the publisher of the blo
Team Relationship Management
Team Digital Tech
Press
Dr. Tanja Emmerling appointed Partner of High-Tech Gründerfonds
Since March 2018, Dr. Tanja Emmerling (41 years) has headed the Berlin office of High-Tech Gründerfonds (HTGF). Now she has been appointed partner. "Following the extremely successful and rapid establishment of the Berlin office, we are very pleased to strengthen the extended management team with Tanja. This will give us even more impact for the entire HTGF", explains Dr. Alex von Frankenberg, Managing Partner of the HTGF. In total, there are eleven partners, more than a quarter of them are wom
Press
Artificial Intelligence for faster and more reliable radiological findings
The use of Artificial Intelligence makes medical findings faster and more reliable:
mediaire GmbH is developing innovative methods that help radiologists detect neurodegenerative diseases, such as Alzheimer's or Multiple Sclerosis, earlier and faster. The High-Tech Gründerfonds (HTGF), together with a group of private investors, is investing a large six-digit amount in the growth of this Berlin-based start-up.
The goal of mediaire GmbH is to increase patient safety and facilitate everyday
Press
“First-in-Class“ mRNA-therapeutics for vascular diseases: Pantherna Therapeutics receives 7-digit investment
The life science start-up Pantherna Therapeutics secures €3.5 million in a successful seed-financing round.
The start-up presents a proprietary, innovative technology platform for the development of novel mRNA therapeutics to treat Acute Respiratory Distress Syndrome (ARDS), a severe lung disease.
The funds will be used to advance R&D activities and hire additional scientific staff.
Investors are the High-Tech Gründerfonds (HTGF), European Business Angel Prof. Detlev Riesner
Press
Emergence Therapeutics Announces a Bumped-up Follow-on Seed Round Financing
Financing enables company to embark on additional targets and expand ADC technology reach
Emergence Therapeutics AG, a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers, announces that is has closed a Bumped-up Follow-on Seed Round Financing from a syndicate of leading European investors comprising Bpifrance through its InnoBio 2 fund, Gründerfonds Ruhr, Heidelberg Pharma Research GmbH, High-Tech Gründerf
Press
miRdetect Receives Seed Financing – Consortium Invests Seven-Digit Amount in Serum Marker for Testicular Cancer Detection
High-Tech Gründerfonds (HTGF), BAB Beteiligungs- und Managementgesellschaft Bremen mbH (BBM) and a private investor invest in Bremen start-up miRdetect
miRdetect develops an innovative and accurate test method for the detection of testicular cancer
Together with BBM and a private investor, High-Tech Gründerfonds (HTGF) is investing a seven-figure sum in the start-up company miRdetect located in Bremen, and founded in 2016. The company founders Meike Spiekermann and Dr. Nina Winter were
Team Chemistry
Press
Coinlend receives HTGF seed funding for its AI-based lending platform tailored to the cryptocurrency market
Coinlend's AI-based technology automates, monitors and maximizes interest
generation through margin funding - the secure financing of leveraged trading
positions - in the cryptocurrency sector. In February 2019, the HTGF did invest in the
company in the six-figure range.
The major trading exchanges in the cryptocurrency sector offer their users the opportunity to
lend their funds to day traders in the form of short-term loans in addition to the actual trading
in crypto and fiat currencie
Press
EUR 3 million in series A for the growth and development of Cytena GmbH
The High-Tech Gründerfonds (HTGF) and two private investors are convinced of the importance of single-cell isolation for the production of biopharmaceuticals and for genetic analysis in research and diagnostics.
EUR 3 million will be invested in the further development of the technology, the expansion of the sales organization and in opening up further applications for Cytena's single-cell printers.
Freiburg-based Cytena GmbH successfully completes another financing round. I
Press
With AI-based document verification against counterfeiters and fraudsters: ICO-LUX receives seed financing
High-Tech Gründerfonds invests in the Jena based InsurTech start-up ICO-LUX. The company pursues an innovative approach to detect insurance fraud automatically. With its self-learning software ICO-LUX can detect manipulation and forgery of digitized paper documents using computer vision and artificial intelligence. This benefits not only major customers in the insurance and financial sector, but also honest end customers.
According to the Association of German Insurers, the insurance
Press
Hanko.io, startup for passwordless authentication, closes seed funding with investors from HTGF and PAYONE founders
The company from Kiel, Germany closes their first investment round successfully. With the High-Tech Gründerfonds (HTGF) and PAYONE founders Carl Frederic Zitscher and Jan Kanieß, Hanko wins over experienced partners for innovative technology and growth. The capital will be used for further product development and the implementation of the go-to-market strategy.
For apps on smartphones and tablets biometric procedures such as Touch ID and Face ID have been established since long. In brow
Press
Plasmion’s SICRIT® sensor technology convinces investors
Plasmion has successfully completed a Series A investment round with strong consortium. In addition to the VC partners Bayrische Beteiligungsgesellschaft (BayBG) and High-Tech Gründerfonds (HTGF), an experienced business angel from the BayStartUP network is also on board. With SICRIT®, Plasmion has developed a novel ionisation technology for mass spectrometry that not only simplifies and improves existing chemical analysis in laboratories, but can also be used industrially as a highly sensitiv
Press
Novel laser technology for biomedicine – Twenty-One Semiconductors successfully closes seed financing round with High-Tech Gründerfonds.
High-Tech Gründerfonds (HTGF) invests in the start-up Twenty-One Semiconductors (21S) as part of a first round of financing. The spin-off from the University of Stuttgart produces semiconductor-based laser crystals for biomedical applications. These crystals enable the realization of laser modules in the yellow spectral range, which is difficult to access with traditional laser technologies. Such yellow lasers are used to significantly increase the information content of biomedical investig